 |
Previous Article | Next Article 
Volume 17, Number 9,
Issue of May 1, 1997
pp. 3157-3167
Copyright ©1997 Society for Neuroscience
The 5-HT3 Receptor Is Present in Different
Subpopulations of GABAergic Neurons in the Rat Telencephalon
Marisela Morales and
Floyd E. Bloom
The Scripps Research Institute, Department of Neuropharmacology, La
Jolla, California 92037
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
FOOTNOTES
REFERENCES
ABSTRACT
The type 3 serotonin receptor (5-HT3R) is a
ligand-gated ion channel whose presence in the CNS has been established
by radioligand binding, in situ hybridization, and
immunohistochemical analysis. To analyze further the role of the
5-HT3R in the CNS, we used in situ
hybridization and immunocytochemistry to determine that 5-HT3R-expressing neurons are mainly GABA-containing cells
in the rat telencephalon. We determined that
5-HT3R/GABA-containing neurons do not exhibit somatostatin
immunoreactivity but often contain cholecystokinin (CCK)
immunoreactivity. 5-HT3R-expressing cells with CCK
immunoreactivity were observed in the neocortex, olfactory cortex,
hippocampus, and amygdala. The 5-HT3R/CCK interneurons represent between 35 and 66% of the total population of CCK-containing cells in the neocortex.
Further characterization of the 5-HT3R/GABAergic neurons
was based on their calcium-binding protein immunoreactivity and showed that these neurons lack parvalbumin (PV) and represent a
subpopulation of calbindin (CB)-containing interneurons that were
preferentially present in the CA1-CA3 subfield of the hippocampus.
Although some 5-HT3R/GABAergic neurons with
calretinin (CR) were found in the neocortex, olfactory cortex,
hippocampus, and amygdala, these neurons were more often present in the
agranular insular and piriform cortices.
We conclude that the neuronal expression of the 5-HT3R is
selective within the GABA neuron population in the rat telencephalon. These 5-HT3R-expressing interneurons might contain CCK, CB,
and CR. We suggest that serotonin through the 5-HT3R may
regulate GABA and CCK neurotransmission in the telencephalon.
Key words:
5-HT3R;
serotonin;
GABA;
interneurons;
calcium-binding proteins;
cholecystokinin
INTRODUCTION
The neurotransmitter serotonin
[5-hydroxytryptamine (5-HT)] interacts with several receptors (Hoyer
et al., 1994 ), all of which are G-protein-coupled (Hoyer et al., 1994 ),
with the exception of the 5-HT3 receptor
(5-HT3R), which is a ligand-gated ion channel (Derkach et
al., 1989 ). Electrophysiological studies on neurons and neuronal cell
lines indicate that stimulation of the 5-HT3R causes a
rapid depolarization produced by an increased membrane permeability to
monovalent cations (Peters and Lambert, 1989 ). The cloning of a
functional subunit of the 5-HT3R (subunit A) from the
neuroblastoma cell line NCB-20 has confirmed that the 5-HT3R is a member of the superfamily of ligand-gated ion
channels and is structurally related to the nicotinic,
GABAA, and NMDA receptors (Manricq et al., 1991).
Radioligand binding studies have detected 5-HT3R binding
sites in the CNS of rodents, primates, and humans (Kilpatrick et al.,
1987 , 1988 , 1989 ; Waeber et al., 1988 , 1989 , 1990 ; Barnes et al.,
1989a , 1990 ; Pratt et al., 1990 ; Gehlert et al., 1991 ; Jones et al.,
1992 ; Laporte et al., 1992 ). High-density 5-HT3R binding
sites have been found in the hindbrain: the nucleus of the tractus
solitarius, area postrema, nucleus of the spinal tract of the
trigeminal nerve, and dorsal motor nucleus of the vagus (Waeber et al.,
1988 , 1989 , 1990 ; Barnes et al., 1990 ; Pratt et al., 1990 ; Gehlert et
al., 1991 ; Jones et al., 1992 ; Laporte et al., 1992 ). Moderately dense
5-HT3R binding sites have been found consistently in
cortex, amygdala, and hippocampus (Kilpatrick et al., 1987 , 1988 ;
Waeber et al., 1988 ; 1989 ; 1990 ; Barnes et al., 1989a ; Gehlert et al.,
1991 ; Jones et al., 1992 ; Laporte et al., 1992 ). In contrast, only a
few studies have reported specific binding sites in the nucleus
accumbens, striatum, or substantia nigra (Kilpatrick et al., 1987 ;
Waeber et al., 1988 ; Gehlert et al., 1991 ; Laporte et al., 1992 ). The
presence of neurons containing 5-HT3R has been confirmed in
some of these brain areas by in situ hybridization (Tecott
et al., 1993 ; D. Johnson and S. Heinemann, personal communication) and
immunocytochemical analysis (Morales et al., 1996a ).
The function of the 5-HT3R in the CNS as well as in the
neuronal circuits in which this receptor might participate remains to
be established. The use of 5-HT3R antagonists in behavioral studies, however, has led to the view that this receptor participates in several pharmacological events, such as anxiolytic, antipsychotic, and cognitive-enhancing actions and facilitation of the withdrawal from
drugs of abuse (Carboni et al., 1989 ; Costall et al., 1990 , 1993 ;
Nevins and Anthony, 1994 ). In addition, activation of
5-HT3R has been demonstrated to modulate the release of
various neurotransmitters in the brain (Barnes et al., 1989b ; Blandina
et al., 1989 ; Chen et al., 1991 , 1992 ; Paudice and Raiteri, 1991 ; Maura
et al., 1992 ).
To obtain information on the functional significance of the
5-HT3R-containing neurons, we sought to determine
additional neurochemical features of the neurons that express this
receptor in the telencephalon.
MATERIALS AND METHODS
Tissue preparation. Twenty adult male Sprague Dawley
20 rats (100-120 gm body weight) were anesthetized with choral hydrate (3.5 mg/100 gm body weight) and perfused transcardially with a solution
of 4% paraformaldehyde in 0.1 M phosphate buffer (PB), pH
7.3. Brains were post-fixed overnight, rinsed with PB, and sequentially
transferred to 12%, 14%, and 16% sucrose solutions. Brains were then
frozen on dry ice, and sections of 30-40 µm thickness were obtained
on a cryostat.
Probe preparation. [35S]- and
[33P]-labeled sense and antisense RNA probes were
generated from a 730 basepair (bp) PstI insert (corresponding to nucleotides 1500-2230 of the rat 5HT3R
cDNA), using the TransProbe T Kit (Pharmacia, Piscataway, NJ). The
[35S]- and [33P]-labeled antisense probes
were synthesized separately.
In situ hybridization-immunocytochemistry labeling. In situ hybridization combined with immunolabeling was
performed as described previously (Morales et al., 1996a ).
Free-floating cryosections were incubated in PB supplemented with 0.5%
Triton X-100 for 10 min, rinsed 2 × 5 min with PB, treated with
0.2N HCl for 10 min, rinsed 2 × 5 min with PB, and then
acetylated in 0.25% acetic anhydride in 0.1 M
triethanolamine, pH 8.0, for 10 min. Sections were rinsed 2 × 5 min with PB and post-fixed with 4% paraformaldehyde for 10 min, and
after a final rinse with PB, sections were prehybridized for 3 hr at
55°C in hybridization buffer (50% formamide, 10% dextran sulfate,
5× Denhardt's solution, 0.62 M NaCl, 50 mM
dithiothreitol, 10 mM EDTA, 20 mM PIPES, pH
6.8, 0.2% SDS, 250 µg/ml ssDNA, 250 µg/ml tRNA). After
prehybridization, sections were hybridized at 55°C for 16 hr in
hybridization buffer containing [35S]- and
[33P]-labeled single-stranded RNA probes at
107 cpm/ml. Sections were treated with RNase A at 4 µg/ml
at 37°C for 1 hr, washed in 1 × SSC, 50% formamide at 55°C
for 2 hr, and in 0.1 × SSC at 68°C for 1 hr. Sections were
rinsed with PB, incubated in 1% bovine serum albumin (BSA)
supplemented with 0.3% Triton X-100 in PB for 1 hr, and then incubated
with the corresponding primary antibody for 24 hr at 4°C. A
previously well characterized rabbit polyclonal antibody against SS,
SS-320 (Morrison et al., 1983 ), was used at dilution 1:3000 (antibody
was provided by Dr. R. Benoit, Montreal, Quebec, Canada); anti-GABA
rabbit antibody (Sigma, St. Louis, MO) was used at dilution 1:2000. A
specific anti-cholecystokinin (CCK) monoclonal antibody raised in mouse was used at dilution 1:2000 (provided by Dr. D. Goodwillie, Farmitalia Carlo Erba, Nerviano, Italy), and anti-parvalbumin (PV), anti-calbindin (CB) mouse monoclonal, and anti-calretinin (CR) rabbit polyclonal antibodies were used at dilution 1:2000 (Swant).
After sections were rinsed 3 × 10 min in PB, they were processed
with an ABC kit (Vector, Burlingame, CA). Material was incubated in a
1:200 dilution of the corresponding biotinylated secondary antibody.
After they were rinsed with PB, sections were incubated with
avidin-biotinylated horseradish peroxidase for 2 hr. Samples were
rinsed, and the peroxidase reaction was developed with 0.05% 3,3-diaminobenzidine-4 HCl (DAB) and 0.003% hydrogen peroxide (H2O2). All antibody dilutions were performed
in PB supplemented with 1% BSA and 0.3% Triton X-100. Sections were
mounted on coated slides, air-dried, dipped in nuclear track emulsion,
and exposed for several weeks before development. Material was
photographed under bright-field or epiluminescence microscopy.
When hybridization was performed with sense probes, few silver grains
were scattered on the sections. This level of signal was very low and
was considered as unspecific background. In contrast, hybridization
with antisense probes resulted in a localized signal distribution.
Double immunocytochemistry. Free-floating cryosections were
processed as described under immunocytochemistry. Sections were incubated with a specific rabbit polyclonal anti-5-HT3R
antibody (0165) at 1:4000 dilution for 24-48 hr at 4°C. We have
established previously the specificity of the anti-5-HT3R
antibody used in this study (Morales et al., 1996a ). After the
peroxidase reaction was developed with DAB and
H2O2, the sections were rinsed with PB, and the
remaining hydrogen peroxidase activity was inactivated by incubating
sections in methanol containing 0.3% H2O2 for
15 min at room temperature. After several rinses with PB, sections were
treated with an avidin solution (Vector) to block biotin groups for 1 hr at room temperature. Sections were incubated in the second primary
antibody (anti-CCK at 1:2000 dilution) supplemented with
biotin-blocking solution (Vector) and incubated for 24 hr at 4°C.
After they were rinsed 3 × 10 min in PB, sections were processed
with an ABC kit (Vector). Material was incubated in a 1:200 dilution of
anti-mouse biotinylated secondary antibody. After sections were rinsed
with PB, they were incubated with avidin-biotinylated horseradish
peroxidase for 2 hr. Samples were rinsed with 0.1 M sodium
phosphate buffer (SPB), pH 6.8, and the peroxidase reaction was
developed in 0.01% benzidine dihydrochloride, 0.025% sodium nitroferricyanide, and 0.005% H2O2 in SPB
(Levey et al., 1986 ), which results in a granular blue-black reaction
product.
Data analysis. Sections processed for in situ
hybridization and immunocytochemistry were analyzed and photographed
with bright-field or epiluminescence microscopy. We performed a
semiquantitative analysis of double-labeled cells in the neocortex. A
neuron was considered double-labeled when its soma was brown and
contained more than 15 silver grains. In pilot experiments we found
that 15-20 silver grains represent weak label above background.
Double-labeled cells were counted in three random sections of three
different experiments, and the percentage of neurons containing both
5-HT3R mRNA and immunoreactivity was calculated from the
total population of immunolabeled cells.
RESULTS
We have previously used in situ hybridization and
immunocytochemistry to show the presence of GABA in neurons that
express the 5-HT3R in the neocortex and hippocampus
(Morales et al., 1996b ). In the present study, we investigated further
the neurochemical composition of 5-HT3R-expressing neurons
in the telencephalon.
Colocalization of 5-HT3R transcripts
and GABA
Coexistence of 5-HT3R transcripts with GABA
immunoreactivity was observed in several areas of the telencephalon.
These 5-HT3R/GABA neurons were often found in those brain
areas that contained cells with high levels of 5-HT3R
expression, such as the neocortex (Fig. 1A,B), olfactory regions, hippocampal
formation, amygdaloid complex, and septal region (Fig.
2A,B). Double-labeled cells were also detected occasionally in areas in which neurons contained low levels of
5-HT3R mRNA, such as the corpus callosum, corpus striatum, thalamus, and hypothalamus. A semiquantitative analysis performed from
three random sections of three different experiments indicated that
between 70 and 95% of the 5-HT3R-expressing cells were
GABAergic throughout the telencephalon (n = 550 cells).
Fig. 1.
Simultaneous detection of 5-HT3R
transcripts and GABA immunoreactivity in layer II of parietal cortex.
A, Observation of 5-HT3R-expressing cells
under epiluminescence microscopy. B, Observation of
GABA-immunoreactive neurons under bright-field microscopy. In this
section, all 5-HT3R-expressing cells showed GABA
immunoreactivity (filled arrows in
A and B), but not all GABA-immunoreactive
neurons contained 5-HT3R transcripts (open
arrows in B). Scale bar, 25 µm.
[View Larger Version of this Image (162K GIF file)]
Fig. 2.
Simultaneous detection of 5-HT3R
transcripts and GABA immunoreactivity in the medial septal nucleus.
A, Observation of 5-HT3R-expressing cells
under epiluminescence microscopy. B, Observation of
GABA-immunoreactive neurons under bright-field microscopy.
Double-labeled cells are indicated by arrows. Scale bar,
25 µm.
[View Larger Version of this Image (132K GIF file)]
The 5-HT3R/GABAergic neurons were found throughout the
different layers of the neocortex but were preferentially concentrated in layers II-III and V-VI. This pattern of distribution was observed from the frontal to the occipital regions of the neocortex. Within the
olfactory regions, 5-HT3R/GABAergic neurons were detected in the olfactory tubercle, piriform cortex, endopiriform nucleus, anterior olfactory nucleus, and taenia tecta. The
5-HT3R/GABAergic neurons of the hippocampal formation were
distributed in all layers of the CA1-CA3 subfields of the hippocampus,
dentate gyrus, hilus, and subiculum. The 5-HT3R/GABAergic
cells of the amygdaloid complex were found mainly in the lateral,
basolateral, basomedial, and cortical amygdaloid nuclei.
Colocalization of 5-HT3R transcripts
and neuropeptides
Somatostatin (SS) and CCK are neuropeptides known to coexist with
GABA in nonoverlapping neuronal populations in the cortex and
hippocampus (Somogyi et al., 1984 ; Sloviter and Nilaver, 1987 ). Thus,
we investigated whether either of these peptides was present in the
5-HT3R-expressing neurons. No SS immunoreactivity was found in any 5-HT3R-expressing neurons, although single
SS-immunopositive or 5-HT3R-expressing neurons were
identified readily in cortex and hippocampus. In contrast, CCK
immunoreactivity was often observed in 5-HT3R-expressing
neurons of the neocortex (Fig. 3A,B),
olfactory regions (Fig. 3C,D), hippocampal formation, and
amygdaloid complex.
Fig. 3.
Simultaneous detection of 5-HT3R
transcripts and CCK immunoreactivity in the temporal (A,
B) and piriform (C, D) cortices. A,
C, Observation of 5-HT3R-expressing cells under
epiluminescence microscopy. B, D, Observation of
CCK-immunoreactive neurons under bright-field microscopy. In these
sections, several 5-HT3R-expressing cells showed CCK
immunoreactivity (filled arrows), but not all CCK-immunoreactive neurons contained 5-HT3R transcripts
(open arrows). Scale bar, 25 µm.
[View Larger Version of this Image (85K GIF file)]
Within the neocortex, 5-HT3R/CCK-labeled cells were
distributed mainly in layers II-III, although colocalization was also observed in cells of deeper layers. These double-labeled neurons were
found frequently in the motor, prelimbic, and visual cortices (see
n in Table 1). A semiquantitative analysis
indicated that between 35 and 65% of the CCK-containing cells in
layers II-III of the neocortex (n = 726 cells) express
the 5-HT3R (Table 1). We frequently observed
5-HT3R/CCK-labeled cells in the anterior olfactory nucleus
and piriform cortex, and a semiquantitative evaluation of these cells
showed that 55-65% of the CCK-immunoreactive cells (n = 147 cells) contained 5-HT3R transcripts (Table 1). These
results indicate that the percentage of 5-HT3R/CCK-labeled neurons is not homogenous within the different cortical areas.
Table 1.
Percentage of CCK-immunoreactive neurons expressing the
5-HT3R
| Region |
Percentage of double-labled
neuronsa |
|
| Neocortex |
| Motor
cortex |
49
± 0.47 (n = 119) |
| Agranular insular cortex |
35
± 0.47 (n = 25) |
| Anterior cingulate cortex |
60
± 0.47 (n = 62) |
| Auditory cortex |
36
± 0.47 (n = 113) |
| Posterior parietal association
cortex |
66 ± 0.47 (n = 55) |
| Prelimbic
cortex |
55 ± 0.47 (n = 89) |
| Somatosensory
cortex |
35 ± 0.47 (n = 70) |
| Visual
cortex |
46 ± 0.47 (n = 193) |
| Olfactory
system |
| Anterior olfactory nucleus |
65
± 0.47 (n = 45) |
| Piriform cortex |
53
± 0.47 (n = 102) |
| Entorhinal cortex |
55
± 0.47 (n = 75) |
|
|
a
Total number of CCK-immunopositive cells
(n) was counted in three sections each from three different
experiments, and the percentage of CCK-immunoreactive cells expressing
the 5-HT3R was calculated.
|
|
5-HT3R/CCK-labeled cells were found scattered
throughout the hippocampus in the stratum (st.) oriens, st. pyramidale,
and st. radiatum of the CA1-CA3. Within the st. oriens,
double-labeled cells were sometimes located near the alveus or close to
the st. pyramidale. The 5-HT3R/CCK-labeled interneurons
were located at the border of the granular cell layer in the dentate
gyrus. Several nuclei of the amygdaloid complex also have
5-HT3R/CCK neurons, mainly the lateral, basolateral,
basomedial, and cortical nuclei.
Colocalization of 5-HT3R and CCK
In another set of experiments, we used an anti-5-HT3R
antibody (Morales et al., 1996a ) for the simultaneous detection of
5-HT3R and CCK immunoreactivity. We found that some
5-HT3R-immunolabeled neurons were also positive for CCK
immunostaining. The pattern of distribution of these
double-immunostained cells parallels that observed for
CCK-immunoreactive/5-HT3R mRNA-hybridized neurons in the
neocortex and the hippocampal formation. Double-immunolabeled cells,
however, were difficult to evaluate when the CCK immunoproduct appeared
as sparse grains or dense aggregates in the cell bodies, limiting
accurate quantitation of double-labeled cells.
Double 5-HT3R/CCK-immunoreactive neurons were scattered in
all layers of the neocortex and occasionally were found in the white
matter. Layers II-III contained the highest density of
5-HT3R/CCK-immunoreactive neurons, and immunoreactive CCK
was observed in the perikarya and processes; however, the
5-HT3R immunoproduct was restricted mainly to the cell
bodies.
Double 5-HT3R/CCK-immunolabeled perikarya were found
in the st. oriens, st. pyramidale, st. radiatum, and st. lacunosum
moleculare of CA1 (Figs. 4A,
5A,B) and CA3 (Fig. 4B) subfields. The
5-HT3R/CCK-labeled interneurons contained
CCK-immunopositive processes extending from the st. oriens to the st.
pyramidale and from the st. radiatum to the st. lacunosum moleculare
(Fig. 5A). In addition, double 5-HT3R/CCK cell bodies located in the st. pyramidale of the
CA1 subfield showed CCK-labeled processes extending into the st.
pyramidale (Fig. 5B). Double
5-HT3R/CCK-immunolabeled perikarya were observed immediately below the granule cell layer of the dentate layer, with
CCK-immunopositive processes entering the granule cell layer (Fig.
5C).
Fig. 4.
Simultaneous detection of 5-HT3R and
CCK immunoreactivity in the CA1 (A) and CA3
(B) subfields of the hippocampus. Colocalization of
5-HT3R (brown) and CCK
(granular blue-black) immunoproducts was found in
several neurons (arrows), but not all
5-HT3R-immunoreactive cells contained CCK immunoreactivity
(arrowheads). Insets in A and B show double-labeled neurons at high magnification.
SR, St. radiatum; SLM, st. lacunosum
moleculare. Scale bar, 12.5 µm; for inset, 6 µm.
[View Larger Version of this Image (157K GIF file)]
Fig. 5.
Simultaneous detection of 5-HT3R and
CCK immunoreactivity in CA1 (A, B) and dentate gyrus
(C). A, Note a 5-HT3R/CCK
double-labeled cell in the SR extending into the
SLM. B, A 5-HT3R/CCK
double-labeled cell in the st. pyramidale (SP) extending
into the cell layer. C, Two 5-HT3R/CCK
double-labeled neurons immediately below the st. granulare
(SG); one of them projects into the granule cell layer
(arrow). SR, St. radiatum;
SLM, st. lacunosum moleculare. Scale bar, 6 µm.
[View Larger Version of this Image (143K GIF file)]
Colocalization of 5-HT3R transcripts and
Ca2+-binding proteins
GABAergic cells are known to contain different
Ca2+-binding proteins, PV, CB, and CR (Baimbridge et al.,
1992 , for review). Thus, we sought to determine whether any of these
proteins were present in 5-HT3R-expressing neurons.
Although no PV immunoreactivity was found in
5-HT3R-expressing neurons, both CB and CR did colocalize with 5-HT3R-expressing neurons.
5-HT3R/CB double-labeled neurons were found occasionally in
the entorhinal cortex and basomedial nucleus of the amygdala. In
contrast, this type of neuron was often observed in basket cells of the
dentate gyrus and the different strata of the hippocampus, preferentially in the st. radiatum of the ventral portion of the CA1
and CA3 subfields (Figs. 6), and a semiquantitative
analysis of double-labeled cells indicated that between 33 and 63% of
the CB-immunoreactive cells (n = 267 cells) expressed
the 5-HT3R in these regions.
Fig. 6.
Simultaneous detection of 5-HT3R
transcripts and CB immunoreactivity in CA3. A,
Observation of 5-HT3R-expressing cells under epiluminescence microscopy. B, Observation of
CB-immunoreactive neurons under bright-field microscopy. In this
section, the majority of 5-HT3R-expressing cells showed CB
immunoreactivity (filled arrows in
A and B), but a few CB-reactive cells
were single-labeled for the protein (open arrows in
B). Note a 5-HT3R-expressing cell without CB
immunoreactivity (open arrow in A). Scale
bar, 22 µm.
[View Larger Version of this Image (101K GIF file)]
5-HT3R/CR double-labeled neurons showed a wider
distribution than those for CB. The 5-HT3R/CR-containing
neurons were scattered throughout the forebrain: neocortex, olfactory
tubercle, endopiriform nucleus, anterior olfactory nucleus, hippocampal
formation, posteromedial cortical, and dorsolateral nuclei of the
amygdala. 5-HT3R/CR double-labeled neurons, however, were
concentrated preferentially in the motor (Figs.
7A,B) agranular, perirhinal, insular, and
piriform cortices. Within the hippocampal formation, these neurons were
distributed mainly in the st. lacunosum moleculare of the subiculum
(Fig. 8A,B) and CA1-CA3 areas.
Fig. 7.
Simultaneous detection of 5-HT3R
transcripts and CR immunoreactivity in the occipital cortex.
A, Observation of 5-HT3R-expressing cells
under epiluminescence microscopy. B, Observation of
CR-immunoreactive neurons under bright field. In this section, several
of the 5-HT3R-expressing cells showed CR immunoreactivity
(filled arrows in A and
B), and few were single-labeled (open
arrows in A and B). Scale bar, 25 µm.
[View Larger Version of this Image (105K GIF file)]
Fig. 8.
Simultaneous detection of 5-HT3R
transcripts and CR immunoreactivity field in the st. lacunosum
moleculare of the subiculum. A, Observation of
5-HT3R-expressing cells under epiluminescence microscopy.
B, Observation of CR-immunoreactive neurons under bright
field. In this section, the majority of 5-HT3R-expressing cells showed CR immunoreactivity (filled arrows
in A and B), and few were single-labeled
(open arrows in A and B).
Scale bar, 18 µm.
[View Larger Version of this Image (158K GIF file)]
DISCUSSION
Characterization OF
5-HT3R/GABA-expressing cells
It has been demonstrated that cortical and hippocampal GABAergic
interneurons are a heterogeneous population with regard to their
morphology, biochemical composition, and synaptic connections (Wolff
and Chronwall, 1982 ; Freund et al., 1983 , 1990 ; Hendry et al., 1984 ;
Somogyi et al., 1984 ; Kosaka et al., 1985 ; Celio, 1986 ; Sloviter and
Nilaver, 1987 ; Katsumaru et al., 1988 ). Various biochemical properties
of the GABAergic interneurons have been widely used to distinguish
subpopulations of GABAergic neurons in cortex and hippocampus (Hendry
et al., 1984 ; Somogyi et al., 1984 ; Kosaka et al., 1985 ; Celio, 1986 ;
Sloviter and Nilaver, 1987 ; Katsumaru et al., 1988 ; Freund et al.,
1990 ). Subpopulations of GABAergic neurons can be identified according
to their calcium-binding protein (i.e., PV, CB, and CR) or neuropeptide
content (i.e., SS and CCK). Our data indicate that the
5-HT3R/GABA-expressing neurons belong to a distinct group
of GABAergic cells that lack SS and PV but may contain CCK, CB, and CR.
These three subgroups of 5-HT3R/GABAergic interneurons have
a distinct regional distribution, which is consistent with observations
from cortical and hippocampal interneurons showing that PV- and
CB-containing neurons form two different populations of GABAergic
neurons that do not coexist with CCK (Hendry et al., 1984 ; Hendry and
Jones, 1985 ; Gulyás et al., 1991 ). These data support the view
that the 5-HT3R-containing neurons are composed of a
biochemically heterogeneous subpopulation of neurons that may be
involved in different inhibitory circuits.
Coexistence of 5-HT3R and CCK within the
same cells
Previous studies have shown that the vast majority of
cortical and hippocampal CCK-containing neurons are GABAergic in the rat brain (Hendry et al., 1984 ; Somogyi et al., 1984 ; Kosaka et al.,
1985 ). We found that the 5-HT3R, which is expressed in some interneurons, is present in a subpopulation of CCK-immunoreactive neurons in the neocortex, olfactory system, and hippocampal
formation.
The colocalization of 5-HT3R and CCK immunoreactivity
within some interneurons implies functional interactions between
serotonergic terminals and CCK-containing cells. In addition, the
findings that 35-66% of the CCK-containing cells in layers II-III of
the neocortex and 55-65% of neurons of the anterior olfactory nucleus and piriform cortex express the 5-HT3R suggest that CCK
neurotransmission is highly regulated by serotonin in the rat
telencephalon. The presence, however, of putative serotonergic contacts
on CCK cells has not yet been reported. In contrast, some neurochemical
studies indicate that 5-HT3R activation is capable of
mediating the release of CCK. Paudice and Raiteri (1991) demonstrated
that serotonin or 1-phenylbiguanide, a selective 5-HT3R
agonist, enhances the depolarization-evoked release of CCK from
synaptosomes prepared from rat cerebral cortex, and this effect was
prevented by 5-HT3R antagonists. The 5-HT3R
antagonists also prevent the veratrine-evoked release of CCK in frontal
cortex of freely moving rats (Raiteri et al., 1993 ), suggesting that
activation of 5-HT3R on CCK-releasing nerve endings might
mediate the release of CCK. These pharmacological studies did not show
which of the two possible sources of CCK in cortex, an intrinsic source
from local CCK-containing cells or an extrinsic one from projections of
the mesencephalon, were the source of released CCK. Our data on the
presence of 5-HT3R/CCK-containing neurons in cortex and
hippocampus suggest that activation of local 5-HT3R/CCK-containing cells might participate in the
release of CCK in cortex and hippocampus.
The activity of hippocampal 5-HT3R/CCK-containing neurons
is likely to be regulated by the raphe nucleus. In addition, another source of regulation might be provided by the septum, because it has
been reported that hippocampal CCK-containing neurons are innervated by
GABAergic septal fibers (Gulyás et al., 1990 ), thus making the
5-HT3R/CCK-containing neurons the target of subcortical pathways such as those originating in the septum and raphe nucleus.
We also detected 5-HT3R/CCK double-immunolabeled neurons
extending into the pyramidal and granule layers of the hippocampus and
dentate gyrus. These results suggest that some of the
5-HT3R/GABA/CCK-containing neurons might inhibit principal
neurons in these regions. In agreement with this suggestion, it is
known that CCK-positive boutons establish symmetrical synaptic contacts
with perikarya and dendrites of pyramidal and nonpyramidal neurons in
hippocampus (Harris et al., 1985 ; Hendry and Jones, 1985 ; Nunzi et
al., 1985 ; Totterdell and Smith, 1986 ), and that CCK immunoreactivity
is found in axonal terminals contacting perikarya of neurons in the
cortex (Köhler and Chan-Palay, 1982 ). The activation of
5-HT3R in CCK-containing interneurons might result in the
direct inhibition of principal neurons, thus affecting areas to which
these principal neurons project (Fig. 9). This
inhibition might occur in pyramidal neurons of the subiculum that
project to the nucleus accumbens and are innervated by
CCK-immunoreactive terminals (Totterdell and Smith, 1986 ).
Fig. 9.
Hypothetical circuitry involving serotonergic
activation of 5-HT3R on inhibitory interneurons.
Serotonin-immunoreactive terminals make asymmetrical synapses on
dendrites of hippocampal and cortical interneurons (Freund et al.,
1990 ; Smiley and Goldman-Rakic, 1996 ); some of these interneurons
containing 5-HT3R and CCK (1) might be
activated by 5-HT, resulting in inactivation of other interneurons (2) and principal neurons. It is known that CCK-positive
boutons establish symmetrical synaptic contacts with perikarya and
dendrites of pyramidal and nonpyramidal neurons in hippocampus (Harris
et al., 1985 ; Hendry and Jones, 1985 ; Nunzi et al., 1985 ; Totterdell and Smith, 1986 ), and that CCK immunoreactivity is found in axonal terminals innervating the perikarya of neurons in the cortex
(Köhler and Chan-Palay, 1982 ). The activation of
5-HT3R in CCK-containing interneurons (1)
might result in the direct inhibition of principal neurons, thus
affecting areas to which these principal neurons project.
[View Larger Version of this Image (20K GIF file)]
Coexistence of 5-HT3R with
Ca2+-binding proteins
The characterization of 5-HT3R/GABAergic neurons on
the basis of the content of their calcium-binding proteins suggests
that these neurons lack PV but may contain CR and CB.
Some 5-HT3R/CR-containing cells were found in the
neocortex, olfactory cortex, hippocampus, and amygdala, but these
neurons were more often present in the agranular insular and piriform cortices. In contrast, the 5-HT3R/CB double-labeled neurons
were found mainly in the CA1-CA3 subfields of the hippocampus. These results are consistent with previous observations showing that serotonergic median raphe axons selectively innervate the somata and
dendritic trees of CB-containing GABAergic interneurons in the CA1 and
CA3 subfields of the rat hippocampus, but never those that contain PV
(Freund et al., 1990 ; Halasy et al., 1992 ; Hornung and Celio, 1992 ;
Miettinen et al., 1992 ). Likewise, CR-immunoreactive neurons of the
hippocampus also receive serotonergic synaptic contacts from the median
raphe nuclei (Acsády et al., 1993 ). In addition, the hippocampal
CB- and CR-immunoreactive neurons receive innervations from the medial
septum (Freund and Antal, 1988 ; Freund et al., 1990 ; Gulyás et
al., 1990 ; Acsády et al., 1993 ). The CB-containing interneurons
are mainly basket and axo-axonic cells that make symmetrical synapses
on the soma of the principal cells but also contact the axon initial
segments, proximal dendrites, and dendritic spines of the pyramidal
cells (Katsumaru et al., 1988 ; DeFelipe et al., 1989 ). The presence of
CB and CR in 5-HT3R-expressing interneurons suggests that
these interneurons might belong to those hippocampal CB- and
CR-immunoreactive neurons shown previously to be innervated by
subcortical inputs from the medial septal and median raphe nuclei. In
addition, these 5-HT3R/CB and 5-HT3R/CR interneurons might modulate neuronal transmission of interneurons and
principal neurons.
In the present study we demonstrated that the neuronal expression
of the 5-HT3R is selective within the GABA neuron
population in the rat telencephalon, extending preliminary observations
showing that 5-HT3R transcripts coexist with GABA in the
neocortex and hippocampus (Morales et al., 1996b ). Despite the
extensive colocalization of 5-HT3R transcripts and GABA in
the same neurons throughout the telencephalon, the expression of the
5-HT3R is not restricted to GABAergic cells in the CNS; for
instance, we have detected 5-HT3R mRNA in some dopaminergic
neurons of the mesencephalon (M. Morales and F. E. Bloom, unpublished
observations) and in motoneurons of the dorsal horn of the spinal cord
(Morales et al., 1996a ).
The widespread colocalization of 5-HT3R transcripts and
GABA in the same neurons suggests the participation of
5-HT3R in the excitation of inhibitory neurons in several
brain regions. Consistent with these observations, previous
immunohistochemical studies have shown that serotonin-immunoreactive
terminals make asymmetrical synapses on dendrites of hippocampal and
cortical interneurons (Freund et al., 1990 ; Smiley and Goldman-Rakic,
1996 ). Furthermore, 5-HT directly excites GABAergic interneurons via
5-HT3R and consequently increases the frequency of
inhibitory synaptic events recorded in CA1 pyramidal cells of rat
hippocampal slices (Ropert and Guy, 1991 ). Although no similar
electrophysiological findings have been reported in cortical areas, it
is likely that some of the 5-HT3R/GABAergic cortical
neurons will also inhibit cortical pyramidal neurons or interneurons.
The enhancement of GABAergic inhibition by activation of
5-HT3R might be relevant for brain regulatory events,
because 5-HT3R agonists will inhibit the induction of long-term potentiation (LTP) in CA1 and CA3 (Corradetti et al., 1992 ;
Maeda et al., 1994 ) through the facilitation of GABAergic neurons (via
GABAA receptors). In addition, intraperitoneal
administration of the 5-HT3R antagonist ondansetron
increased the frequency of the hippocampal theta rhythm, the induction
of LTP in CA1, and the retention of olfactory and spatial memory in
freely moving rats, suggesting that 5-HT3R blockage of
GABAergic cells results in the disinhibition of pyramidal cells
(Stäubli and Xu, 1995 ). These observations suggest that the
5-HT3R might participate in inhibitory and disinhibitory
circuits in the rat telencephalon.
Relations to other 5-HT receptor localizations
The functional role played by the 5-HT3R we have
localized to GABA-containing interneurons provides only one facet of
what may be viewed as serotonergic synaptic functions in the cerebral cortex and hippocampal formation. Clearly, the 5-HT3R is
only one of several 5-HT receptor subclasses whose cellular locations have already been assessed. In several recent studies on the cellular distribution of other 5-HT receptors, only the 5-HT2R
(Molineaux et al., 1989 ; Morilak et al., 1993 ; Freund and Buzsaki,
1996 ) has been detected on interneurons in addition to the
5-HT3R; however, the 5-HT2R is also present in
principal neurons (Morilak et al., 1993 ; Hamada et al., 1996 ). The
other major subtypes of 5-HT receptors, such as the 5HT1AR
(Gerard et al., 1994 ) and the 5HT6R (Miquel et al., 1996 )
have been attributed only to the pyramidal neurons of the hippocampus
but were not detected in interneurons. Although such studies cannot
define precise roles for the different 5-HT-transducing target neurons,
the contrasting localization may provide the basis for developing
hypotheses for future pharmacological analyses.
In conclusion, we demonstrated that the 5-HT3R-expressing
neurons are mainly GABAergic in the rat telencephalon, suggesting that
depolarization of these cells by serotonin might regulate inhibitory
and disinhibitory circuits in the rat telencephalon. The
5-HT3R-expressing cells might contain CCK, CB, and CR. This biochemical heterogeneity may reflect the participation of these neurons in different inhibitory circuits. In addition, the high degree
of coexistence between the 5-HT3R and CCK is indicative of
the importance that the 5-HT3R has in regulating CCK
neurotransmission in the neocortex.
FOOTNOTES
Received Oct. 1, 1996; revised Jan. 27, 1997; accepted Feb. 10, 1997.
This work was supported by National Institute on Alcohol Abuse and
Alcoholism Grant AA 06420. We thank Drs. David Johnson and Steve
Heinemann for the rat 5-HT3R-A cDNA clone, and Elena Battenberg for her role in early experiments.
Correspondence should be addressed to Marisela Morales, The Scripps
Research Institute, Department of Neuropharmacology, SBR-1, 10550 North
Torrey Pines Road, La Jolla, CA 92037.
REFERENCES
-
Acsády L,
Halasy K,
Freund TF
(1993)
Calretinin is present in non-pyramidal cells of the rat hippocampus-III: their inputs from the median raphe and medial septal nuclei.
Neuroscience
52:829-841[Web of Science][Medline].
-
Baimbridge KG,
Celio MR,
Rogers JH
(1992)
Calcium-binding proteins in the nervous system.
Trends Neurosci
15:303-308[Web of Science][Medline].
-
Barnes JM,
Barnes NM,
Costall B,
Ironside JW,
Naylor RJ
(1989a)
Identification and characterization of 5-hydroxytryptamine3 recognition sites in human brain tissue.
J Neurochem
53:1787-1793[Web of Science][Medline].
-
Barnes JM,
Barnes NM,
Costall B,
Naylor RJ,
Tyers MB
(1989b)
5-HT3 receptors mediate inhibition of acetylcholine release in cortical tissue.
Nature
338:762-763[Medline].
-
Barnes JM,
Barnes NM,
Champaneria S,
Costall B,
Naylor RJ
(1990)
Characterization and autoradiographic localization of 5-HT3 receptor recognition sites identified with [3H]-(S)-zacopride in the forebrain of the rat.
Neuropharmacology
29:1037-1045[Web of Science][Medline].
-
Blandina P,
Goldfarb J,
Craddock-Royal B,
Green JP
(1989)
Release of endogenous dopamine by stimulation of 5-hydroxytryptamine3 receptors in rat striatum.
J Pharmacol Exp Ther
251:803-809[Abstract/Free Full Text].
-
Carboni E,
Acquas E,
Leone P,
Di Chiara G
(1989)
5-HT3 receptor antagonists block morphine- and nicotine- but not amphetamine-induced reward.
Psychopharmacology
97:175-178[Medline].
-
Celio MR
(1986)
Parvalbumin in most
-aminobutyric acid-containing neurons of the rat cerebral cortex.
Science
231:995-997[Abstract/Free Full Text]. -
Chen J,
van Praag HM,
Gardner EL
(1991)
Activation of 5-HT3 receptor by 1-phenylbiguanide increases dopamine release in the rat nucleus accumbens.
Brain Res
543:354-357[Web of Science][Medline].
-
Chen J,
Paredes W,
van Praag HM,
Lowinson JH,
Gardner EL
(1992)
Presynaptic dopamine release is enhanced by 5-HT3 receptor activation in medial prefrontal cortex of freely moving rats.
Synapse
10:264-266[Web of Science][Medline].
-
Corradetti R,
Ballerini L,
Pugliese AM,
Pepeu G
(1992)
Serotonin blocks the long-term potentiation induced by primed burst stimulation in the CA1 region of rat hippocampal slices.
Neuroscience
46:511-518[Web of Science][Medline].
-
Costall B,
Naylor RJ,
Tyers MB
(1990)
The psychopharmacology of 5-HT3 receptors.
J Pharmacol Ther
47:181-202.
-
Costall B,
Domeney AM,
Kelly ME,
Tomkins DM,
Naylor RJ,
Wong EH,
Smith WL,
Whiting RL,
Eglen RM
(1993)
The effect of the 5-HT3 receptor antagonist, RS-42358-197, in animal models of anxiety.
Eur J Pharmacol
234:91-99[Web of Science][Medline].
-
DeFelipe J,
Hendry SHC,
Jones EG
(1989)
Synapses of double bouquet cells in monkey cerebral cortex visualized by calbindin immunoreactivity.
Brain Res
503:49-54[Web of Science][Medline].
-
Derkach V,
Suprenant A,
Northand RA
(1989)
5-HT3 receptors are membrane ion channels.
Nature
33:706-709.
-
Freund TF,
Antal M
(1988)
GABA-containing neurons in the septum control inhibitory interneurons in the hippocampus.
Nature
336:170-173[Medline].
-
Freund TF,
Buzsaki G
(1996)
Interneurons of the hippocampus.
Hippocampus
6:347-470[Web of Science][Medline].
-
Freund TF,
Martin KAC,
Smith AD,
Somogyi P
(1983)
Glutamate decarboxylase-immunoreactive terminals of Golgi-impregnated axo-axonic cells and of presumed basket cells in synaptic contact with pyramidal cells of the cat's visual cortex.
J Comp Neurol
221:263-278[Web of Science][Medline].
-
Freund TF,
Gulyás AI,
Acsády L,
Görcs T,
Tóth K
(1990)
Serotonergic control of the hippocampus via local inhibitory interneurons.
Proc Natl Acad Sci USA
87:8501-8505[Abstract/Free Full Text].
-
Gehlert DR,
Gackenheimer SL,
Wong DT,
Robertson DW
(1991)
Localization of 5-HT3 receptors in the rat brain using [3H]LY278584.
Brain Res
553:149-154[Web of Science][Medline].
-
Gerard C,
Langlois X,
Gingrich J,
Doucet E,
Verge D,
Kia HK,
Raisman R,
Gozlan H,
Mestikawy SEL,
Hamon M
(1994)
Production and characterization of polyclonal antibodies recognizing the intracytoplasmic third loop of the 5 hydroxytryptamine 1A receptor.
Neuroscience
62:721-739[Web of Science][Medline].
-
Gulyás AI,
Görcs TJ,
Freund TF
(1990)
Innervation of different peptide-containing neurons in the hippocampus by GABAergic septal afferents.
Neuroscience
37:31-44[Web of Science][Medline].
-
Gulyás AI,
Tóth K,
Dános P,
Freund TF
(1991)
Subpopulation of GABAergic neurons containing parvalbumin, calbindin D28k, and cholecystokinin in the rat hippocampus.
J Comp Neurol
312:371-378[Web of Science][Medline].
-
Halasy K,
Miettinen R,
Szabat E,
Freund TF
(1992)
GABAergic interneurons are the major postsynaptic targets of median raphe afferents in the rat dentate gyrus.
Eur J Neurosci
4:144-153[Web of Science][Medline].
-
Hamada S,
Senzaki K,
Tabuchi K,
Yamamoto H,
Yamamoto T,
Yoshikawa S,
Okano H,
Okado N
(1996)
Localization of 5-HT2A receptor in rat cerebral cortex by immunohistochemistry.
Soc Neurosci Abstr
22:1774.
-
Harris KM,
Marshall PE,
Landis DMD
(1985)
Ultrastructural study of cholecystokinin-immunoreactive cells and processes in area CA1 of the rat hippocampus.
J Comp Neurol
233:147-158[Web of Science][Medline].
-
Hendry SHC,
Jones EG
(1985)
Morphology of synapses formed by cholecystokinin-immunoreactive axon terminals in regio superior of rat hippocampus.
Neuroscience
16:57-68[Web of Science][Medline].
-
Hendry SHC,
Jones EG,
DeFelipe J,
Schmechel D,
Brandon C,
Emson PC
(1984)
Neuropeptide-containing neurons of the cerebral cortex are also GABAergic.
Proc Natl Acad Sci USA
81:6526-6530[Abstract/Free Full Text].
-
Hornung JP,
Celio MR
(1992)
The selective innervation by serotonergic axons of calbindin-containing interneurons in the neocortex and hippocampus of the marmoset.
J Comp Neurol
320:457-467[Web of Science][Medline].
-
Hoyer D,
Clarke DE,
Fozard JR,
Hartig PR,
Martin GR,
Mylecharane EJ,
Saxena PR,
Humphrey PPA
(1994)
International union of pharmacology classification of receptors for 5-hydroxytryptamine (serotonin).
Pharmacol Rev
46:157-203[Abstract].
-
Jones DN,
Barnes NM,
Costall B,
Domeney AM,
Kilpatrick GJ,
Naylor RJ,
Tyers MB
(1992)
The distribution of 5-HT3 recognition sites in the marmoset brain.
Eur J Pharmacol
215:63-67[Web of Science][Medline].
-
Katsumaru H,
Kosaka T,
Heizmann CW,
Hama K
(1988)
Immunocytochemical study of GABAergic neurons containing the calcium-binding protein parvalbumin in the rat hippocampus.
Exp Brain Res
72:347-362[Web of Science][Medline].
-
Kilpatrick GJ,
Jones BJ,
Tyers MB
(1987)
Identification and distribution of 5-HT3 receptors in rat brain using radioligand binding.
Nature
330:746-748[Medline].
-
Kilpatrick GJ,
Jones BJ,
Tyers MB
(1988)
The distribution of specific binding of the 5-HT3 receptor ligand [3H]GR65630 in rat brain using quantitative autoradiography.
Neurosci Lett
94:156-160[Web of Science][Medline].
-
Kilpatrick GJ,
Jones BJ,
Tyers MB
(1989)
Binding of the 5-HT3 ligand, [3H]GR65630, to rat area postrema, vagus nerve and the brains of several species.
Eur J Pharmacol
159:157-164[Web of Science][Medline].
-
Köhler C,
Chan-Palay V
(1982)
The distribution of cholecystokinin-like immunoreactive neurons and nerve terminals in the retrohippocampal region in the rat and guinea-pig.
J Comp Neurol
210:136-146[Web of Science][Medline].
-
Kosaka T,
Kosaka K,
Tateishi K,
Hamaoka Y,
Yanaihara N,
Wu J-Y,
Hama K
(1985)
GABAergic neurons containing CCK-8-like and/or VIP-like immunoreactivities in the rat hippocampus and dentate gyrus.
J Comp Neurol
239:420-430[Web of Science][Medline].
-
Laporte AM,
Koscielniak T,
Ponchant M,
Verge D,
Hamon M,
Gozlan H
(1992)
Quantitative autoradiographic mapping of 5-HT3 receptors in the rat CNS using [125I]iodo-zacopride and [3H]zacopride as radioligands.
Synapse
10:271-281[Web of Science][Medline].
-
Levey AI,
Bolam JP,
Rye DB,
Hallenger AE,
Demuth RM,
Mesulum M-M,
Wainer BH
(1986)
A light and electron microscopic procedure for sequential double antigen localization using diamine benzidine and benzidine dihydrochloride.
J Histochem Cytochem
34:1449-1457[Abstract].
-
Maeda T,
Kaneko S,
Satoh M
(1994)
Inhibitory influence via 5-HT3 receptors on the induction of LTP in mossy fiber-CA3 system of guinea-pig hippocampal slices.
Neurosci Res
18:277-282[Web of Science][Medline].
-
Maricq AV,
Peterson AS,
Brake AJ,
Myers RM,
Julius D
(1991)
Primary structure and functional expression of the 5HT3 receptor, a serotonin-gated ion channel.
Science
254:432-437[Abstract/Free Full Text].
-
Maura G,
Andrioli GC,
Cavazzani P,
Raiteri M
(1992)
5-Hydroxytryptamine3 receptors sited on cholinergic axon terminals of human cerebral cortex mediate inhibition of acetylcholine release.
J Neurochem
58:2334-2336[Web of Science][Medline].
-
Miettinen R,
Gulyás AI,
Baimbridge KG,
Jacobowitz DM,
Freund TF
(1992)
Calretinin is present in non-pyramidal cells of the rat hippocampus-II: co-existence with other calcium binding proteins and GABA.
Neuroscience
48:29-43[Web of Science][Medline].
-
Miquel MC,
Lefevre K,
Sari Y,
Brisorgueil MJ,
Calas A,
Gerard C,
Hamon M,
Verge D
(1996)
Immunocytochemical visualization of 5HT6 receptors in the rat brain.
Soc Neurosci Abstr
22:1782.
-
Molineaux SM,
Jessell TM,
Axel R,
Julius D
(1989)
5HT1C receptor is a prominent serotonin receptor subtype in the central nervous system.
Proc Natl Acad Sci USA
86:6793-6797[Abstract/Free Full Text].
-
Morales M,
Battenberg E,
de Lecea L,
Sanna PP,
Bloom FE
(1996a)
Cellular and subcellular immunolocalization of the type 3 serotonin receptor in the rat central nervous system.
Mol Brain Res
36:251-260[Medline].
-
Morales M,
Battenberg E,
de Lecea L,
Bloom FE
(1996b)
The type 3 serotonin receptor is expressed in a subpopulation of GABAergic neurons in the rat neocortex and hippocampus.
Brain Res
731:199-202[Web of Science][Medline].
-
Morilak DA,
Garlow SJ,
Ciaranello RD
(1993)
Immunocytochemical localization and description of neurons expressing serotonin 2 receptors in the rat brain.
Neuroscience
54:701-717[Web of Science][Medline].
-
Morrison JH,
Benoit R,
Magistretti PJ,
Bloom FE
(1983)
Immunohistochemical distribution of pro-somatostatin-related peptides in cerebral cortex.
Brain Res
262:344-351[Web of Science][Medline].
-
Nevins ME,
Anthony EW
(1994)
Antagonists at the serotonin-3 receptor can reduce the fear-potentiated startle response in the rat: evidence for different types of anxiolytic activity?
J Pharmacol Exp Ther
268:248-254[Abstract/Free Full Text].
-
Nunzi MG,
Gorio A,
Milan F,
Freund TF,
Somogyi P,
Smith AD
(1985)
Cholecystokinin-immunoreactive cells form symmetrical synaptic contacts with pyramidal and nonpyramidal neurons in the hippocampus.
J Comp Neurol
237:485-505[Web of Science][Medline].
-
Paudice P,
Raiteri M
(1991)
Cholecystokinin release mediated by 5-HT3 receptors in rat cerebral cortex and nucleus accumbens.
Br J Pharmacol
103:1790-1794[Web of Science][Medline].
-
Peters JA,
Lambert JJ
(1989)
Electrophysiology of 5-HT3 receptors in neuronal cell lines.
Trends Pharmacol Sci
10:172-174[Medline].
-
Pratt GD,
Bowery NG,
Kilpatrick GJ,
Leslie RA,
Barnes NM,
Naylor RJ,
Jones BJ,
Nelson DR,
Palacios JM,
Slater P,
Reynolds DJM
(1990)
Consensus meeting agrees distribution of 5-HT3 receptors in mammalian hindbrain.
Trends Pharmacol Sci
11:135-137[Medline].
-
Raiteri M,
Paudice P,
Vallebuona F
(1993)
Inhibition by 5-HT3 receptor antagonists of release of cholecystokinin-like immunoreactivity from the frontal cortex of freely moving rats.
Naunyn Schmiedebergs Arch Pharmacol
347:111-114[Web of Science][Medline].
-
Ropert N,
Guy N
(1991)
Serotonin facilitates GABAergic transmission in the CA1 region of rat hippocampus in vitro.
J Physiol (Lond)
441:121-136[Abstract/Free Full Text].
-
Sloviter R,
Nilaver G
(1987)
Immunocytochemical localization of GABA-, cholecystokinin-, vasoactive intestinal polypeptide-, and somatostatin-like immunoreactivity in the area dentate and hippocampus of the rat.
J Comp Neurol
256:42-60[Web of Science][Medline].
-
Smiley JF,
Goldman-Rakic PS
(1996)
Serotonergic axons in monkey prefrontal cerebral cortex synapse predominantly on interneurons as demonstrated by serial section electron microscopy.
J Comp Neurol
367:431-443[Web of Science][Medline].
-
Somogyi P,
Hodgson AJ,
Smith AD,
Nunzi MG,
Gorio A,
Wu J-Y
(1984)
Different populations of GABAergic neurons in the visual cortex and hippocampus of cat contain somatostatin- or cholecystokinin-immunoreactive material.
J Neurosci
10:2590-2603.
-
Stäubli U,
Xu FB
(1995)
Effects of 5-HT3 receptor antagonism on hippocampal theta rhythm, memory, and LTP induction in the freely moving rat.
J Neurosci
15:2445-2452[Abstract].
-
Tecott LH,
Maricq AV,
Julius D
(1993)
Nervous system distribution of the serotonin 5-HT3 receptor mRNA.
Proc Natl Acad Sci USA
90:1430-1434[Abstract/Free Full Text].
-
Totterdell S,
Smith AD
(1986)
Cholecystokinin-immunoreactive boutons in synaptic contact with hippocampal pyramidal neurons that project to the nucleus accumbens.
Neuroscience
19:181-192[Web of Science][Medline].
-
Waeber C,
Dixon K,
Hoyer D,
Palacios JM
(1988)
Localization by autoradiography of neuronal 5-HT3 receptors in the mouse CNS.
Eur J Pharmacol
151:351-352[Web of Science][Medline].
-
Waeber C,
Hoyer D,
Palacios JM
(1989)
5-hydroxytryptamine3 receptors in the human brain: autoradiographic visualization using [3H]ICS 205-930.
Neuroscience
31:393-400[Web of Science][Medline].
-
Waeber C,
Pinkus LM,
Palacios JM
(1990)
The (S)-isomer of [3H]zacopride labels 5-HT3 receptors with high affinity in rat brain.
Eur J Pharmacol
181:283-287[Web of Science][Medline].
-
Wolff JR,
Chronwall BM
(1982)
Axosomatic synapses in the visual cortex of adult rat: a comparison between GABA-accumulating and other neurons.
J Neurocytol
11:409-425[Web of Science][Medline].
This article has been cited by other articles:

|
 |

|
 |
 
A. W. Moreau, M. Amar, N. Le Roux, N. Morel, and P. Fossier
Serotoninergic Fine-Tuning of the Excitation-Inhibition Balance in Rat Visual Cortical Networks
Cereb Cortex,
July 8, 2009;
(2009)
bhp114v3.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. M. Jasnow, K. J. Ressler, S. E. Hammack, J. P. Chhatwal, and D. G. Rainnie
Distinct Subtypes of Cholecystokinin (CCK)-Containing Interneurons of the Basolateral Amygdala Identified Using a CCK Promoter-Specific Lentivirus
J Neurophysiol,
March 1, 2009;
101(3):
1494 - 1506.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Inta, J. Alfonso, J. von Engelhardt, M. M. Kreuzberg, A. H. Meyer, J. A. van Hooft, and H. Monyer
Neurogenesis and widespread forebrain migration of distinct GABAergic neurons from the postnatal subventricular zone
PNAS,
December 30, 2008;
105(52):
20994 - 20999.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. Fuentealba, R. Tomioka, Y. Dalezios, L. F. Marton, M. Studer, K. Rockland, T. Klausberger, and P. Somogyi
Rhythmically Active Enkephalin-Expressing GABAergic Cells in the CA1 Area of the Hippocampus Project to the Subiculum and Preferentially Innervate Interneurons
J. Neurosci.,
October 1, 2008;
28(40):
10017 - 10022.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Noam, W. J. Wadman, and J. A. van Hooft
On the voltage-dependent Ca2+ block of serotonin 5-HT3 receptors: a critical role of intracellular phosphates
J. Physiol.,
August 1, 2008;
586(15):
3629 - 3638.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Jackson, C. T. Dickson, and B. H. Bland
Median Raphe Stimulation Disrupts Hippocampal Theta Via Rapid Inhibition and State-Dependent Phase Reset of Theta-Related Neural Circuitry
J Neurophysiol,
June 1, 2008;
99(6):
3009 - 3026.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
W. Xiong, M. Hosoi, B.-N. Koo, and L. Zhang
Anandamide Inhibition of 5-HT3A Receptors Varies with Receptor Density and Desensitization
Mol. Pharmacol.,
February 1, 2008;
73(2):
314 - 322.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. B. Fink and M. Gothert
5-HT Receptor Regulation of Neurotransmitter Release
Pharmacol. Rev.,
December 1, 2007;
59(4):
360 - 417.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. A. Hart, M. A. Snyder, T. Smejkalova, and C. S. Woolley
Estrogen Mobilizes a Subset of Estrogen Receptor-{alpha}-Immunoreactive Vesicles in Inhibitory Presynaptic Boutons in Hippocampal CA1
J. Neurosci.,
February 21, 2007;
27(8):
2102 - 2111.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. Kocsis, V. Varga, L. Dahan, and A. Sik
Serotonergic neuron diversity: Identification of raphe neurons with discharges time-locked to the hippocampal theta rhythm
PNAS,
January 24, 2006;
103(4):
1059 - 1064.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. D. Shepard, Y. Liu, P. Sassone-Corsi, and G. Aguilera
Role of Glucocorticoids and cAMP-Mediated Repression in Limiting Corticotropin-Releasing Hormone Transcription during Stress
J. Neurosci.,
April 20, 2005;
25(16):
4073 - 4081.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. V. Puig, F. Artigas, and P. Celada
Modulation of the Activity of Pyramidal Neurons in Rat Prefrontal Cortex by Raphe Stimulation In Vivo: Involvement of Serotonin and GABA
Cereb Cortex,
January 1, 2005;
15(1):
1 - 14.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. Somogyi and T. Klausberger
Defined types of cortical interneurone structure space and spike timing in the hippocampus
J. Physiol.,
January 1, 2005;
562(1):
9 - 26.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Blatow, A. Caputi, and H. Monyer
Molecular diversity of neocortical GABAergic interneurones
J. Physiol.,
January 1, 2005;
562(1):
99 - 105.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. V. Puig, N. Santana, P. Celada, G. Mengod, and F. Artigas
In Vivo Excitation of GABA Interneurons in the Medial Prefrontal Cortex through 5-HT3 Receptors
Cereb Cortex,
December 1, 2004;
14(12):
1365 - 1375.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. Santana, A. Bortolozzi, J. Serrats, G. Mengod, and F. Artigas
Expression of Serotonin1A and Serotonin2A Receptors in Pyramidal and GABAergic Neurons of the Rat Prefrontal Cortex
Cereb Cortex,
October 1, 2004;
14(10):
1100 - 1109.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Neumeister, A. C. Nugent, T. Waldeck, M. Geraci, M. Schwarz, O. Bonne, E. E. Bain, D. A. Luckenbaugh, P. Herscovitch, D. S. Charney, et al.
Neural and Behavioral Responses to Tryptophan Depletion in Unmedicated Patients With Remitted Major Depressive Disorder and Controls
Arch Gen Psychiatry,
August 1, 2004;
61(8):
765 - 773.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. V. Harrell and A. M. Allan
Improvements in Hippocampal-Dependent Learning and Decremental Attention in 5-HT3 Receptor Overexpressing Mice
Learn. Mem.,
September 1, 2003;
10(5):
410 - 419.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. F. FREUND, I. KATONA, and D. PIOMELLI
Role of Endogenous Cannabinoids in Synaptic Signaling
Physiol Rev,
July 1, 2003;
83(3):
1017 - 1066.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. A. van Hooft and W. J. Wadman
Ca2+ Ions Block and Permeate Serotonin 5-HT3 Receptor Channels in Rat Hippocampal Interneurons
J Neurophysiol,
April 1, 2003;
89(4):
1864 - 1869.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Z. Xiang and D. A. Prince
Heterogeneous Actions of Serotonin on Interneurons in Rat Visual Cortex
J Neurophysiol,
March 1, 2003;
89(3):
1278 - 1287.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. N Sudweeks, J. A van Hooft, and J. L Yakel
Serotonin 5-HT3 receptors in rat CA1 hippocampal interneurons: functional and molecular characterization
J. Physiol.,
November 1, 2002;
544(3):
715 - 726.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. C. Foehring, J. F. M. van Brederode, G. A. Kinney, and W. J. Spain
Serotonergic Modulation of Supragranular Neurons in Rat Sensorimotor Cortex
J. Neurosci.,
September 15, 2002;
22(18):
8238 - 8250.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
I. Ferezou, B. Cauli, E. L. Hill, J. Rossier, E. Hamel, and B. Lambolez
5-HT3 Receptors Mediate Serotonergic Fast Synaptic Excitation of Neocortical Vasoactive Intestinal Peptide/Cholecystokinin Interneurons
J. Neurosci.,
September 1, 2002;
22(17):
7389 - 7397.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Morales and S.-D. Wang
Differential Composition of 5-Hydroxytryptamine3 Receptors Synthesized in the Rat CNS and Peripheral Nervous System
J. Neurosci.,
August 1, 2002;
22(15):
6732 - 6741.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
I Aradi and I Soltesz
Modulation of network behaviour by changes in variance in interneuronal properties
J. Physiol.,
January 1, 2002;
538(1):
227 - 251.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Koyama, N. Matsumoto, C. Kubo, and N. Akaike
Presynaptic 5-HT3 receptor-mediated modulation of synaptic GABA release in the mechanically dissociated rat amygdala neurons
J. Physiol.,
December 1, 2000;
529(2):
373 - 383.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F.-M. Zhou and J. J. Hablitz
Activation of Serotonin Receptors Modulates Synaptic Transmission in Rat Cerebral Cortex
J Neurophysiol,
December 1, 1999;
82(6):
2989 - 2999.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C.D. Paspalas and G.C. Papadopoulos
Noradrenergic Innervation of Peptidergic Interneurons in the Rat Visual Cortex
Cereb Cortex,
December 1, 1999;
9(8):
844 - 853.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. E. Dubin, R. Huvar, M. R. D'Andrea, J. Pyati, J. Y. Zhu, K. C. Joy, S. J. Wilson, J. E. Galindo, C. A. Glass, L. Luo, et al.
The Pharmacological and Functional Characteristics of the Serotonin 5-HT3A Receptor Are Specifically Modified by a 5-HT3B Receptor Subunit
J. Biol. Chem.,
October 22, 1999;
274(43):
30799 - 30810.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. D. Mott, Q. Li, M. M. Okazaki, D. A. Turner, and D. V. Lewis
GABAB-Receptor-Mediated Currents in Interneurons of the Dentate-Hilus Border
J Neurophysiol,
September 1, 1999;
82(3):
1438 - 1450.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. G. Rainnie
Serotonergic Modulation of Neurotransmission in the Rat Basolateral Amygdala
J Neurophysiol,
July 1, 1999;
82(1):
69 - 85.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. R. Svoboda, C. E. Adams, and C. R. Lupica
Opioid Receptor Subtype Expression Defines Morphologically Distinct Classes of Hippocampal Interneurons
J. Neurosci.,
January 1, 1999;
19(1):
85 - 95.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. E. Stutzmann, B. S. McEwen, and J. E. LeDoux
Serotonin Modulation of Sensory Inputs to the Lateral Amygdala: Dependency on Corticosterone
J. Neurosci.,
November 15, 1998;
18(22):
9529 - 9538.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Kawaguchi and T. Shindou
Noradrenergic Excitation and Inhibition of GABAergic Cell Types in Rat Frontal Cortex
J. Neurosci.,
September 1, 1998;
18(17):
6963 - 6976.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. De Deurwaerdere, L. Stinus, and U. Spampinato
Opposite Change of In Vivo Dopamine Release in the Rat Nucleus Accumbens and Striatum That Follows Electrical Stimulation of Dorsal Raphe Nucleus: Role of 5-HT3 Receptors
J. Neurosci.,
August 15, 1998;
18(16):
6528 - 6538.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. Roerig and L. C. Katz
Modulation of Intrinsic Circuits by Serotonin 5-HT3 Receptors in Developing Ferret Visual Cortex
J. Neurosci.,
November 1, 1997;
17(21):
8324 - 8338.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. E. Stutzmann and J. E. LeDoux
GABAergic Antagonists Block the Inhibitory Effects of Serotonin in the Lateral Amygdala: A Mechanism for Modulation of Sensory Inputs Related to Fear Conditioning
J. Neurosci.,
June 1, 1999;
19(11):
RC8 - RC8.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
I. Aradi and I. Soltesz
Modulation of network behaviour by changes in variance in interneuronal properties
J. Physiol.,
December 3, 2001;
(2001)
200101305.
[Abstract]
[PDF]
|
 |
|
|